Ulcerative Colitis - Page 7 
The MD Magazine Ulcerative Colitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Fecal Microbiota Transplants Sends Ulcerative Colitis Patients to Remission
Using fecal microbiota transplants (FMT) has sent ulcerative colitis (UC) patients into remission, reported a presentation given at the European Crohn’s and Colitis Organization (ECCO) Congress.
A recent fecal matter transfer (FMT) transferred non-pathogenic viruses from a healthy patient to three pediatric ulcerative colitis patients, according to findings published in mBio.
Microbial changes are a contributing factor to inflammatory bowel disease (IBD) development, according to findings published in Cellular and Molecular Gastroenterology and Hepatology.
The pharmaceutical company Shire won a patent trial concerning mesalamine (Lialda), an ulcerative colitis drug, according to a company press release.
Researchers have developed a fast, simple, and minimally invasive screening test for ulcerative colitis that uses infrared technology.
Inflammatory bowel diseases (IBD) may be countered with worm infection in the gut microbiome, according to successful mice and human studies presented in the journal Science.
Tofacitinib (Xeljans/Pfizer), an oral ulcerative colitis (UC) drug, successfully met key endpoints in two Phase III studies enrolling adult patients with moderate to severe active UC.
Previously associated primarily with assessing blood alcohol level, breath tests can now aid in accurately distinguishing irritable bowel syndrome (IBS).
Men diagnosed with multiple sclerosis often have higher blood pressure than women, in addition to higher levels of diabetes, epilepsy, depression, and anxiety.

Most Popular


$vacMongoViewPlus$ $vAR$